Ocugen (OCGN) Profit After Tax (2014 - 2026)
Ocugen (OCGN) posted Profit After Tax of -$19.2 million for Q1 2026, down 8.72% on a QoQ basis from -$17.7 million in Q4 2025, and down 25.02% year-over-year from -$25.6 million in Q1 2025.
Ocugen (OCGN) Profit After Tax (2014 - 2026) Analysis & Trends
Ocugen's Profit After Tax history runs 13 years deep, the most recent figure standing at -$19.2 million for Q1 2026.
- Quarterly Profit After Tax fell 25.02% year-over-year to -$19.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$71.6 million (down 24.75% YoY) and the FY2025 annual result came in at -$67.8 million, down 25.5% from the prior year.
- Profit After Tax was -$19.2 million for Q1 2026 at Ocugen, down from -$17.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$11.0 million in Q4 2023 and bottomed at -$23.9 million in Q3 2022.
- A 5-year average of -$17.1 million and a median of -$17.3 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax plunged 168.69% — and 2023, when it jumped 51.0%.
- Ocugen's Profit After Tax stood at -$22.4 million in 2022, then jumped by 50.89% to -$11.0 million in 2023, then decreased by 25.69% to -$13.8 million in 2024, then fell by 27.73% to -$17.7 million in 2025, then fell by 8.72% to -$19.2 million in 2026.
- Business Quant data shows OCGN's Profit After Tax at -$19.2 million in Q1 2026, -$17.7 million in Q4 2025, and -$20.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - | -19.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.20 Mn |
| Dec 31, 2025 | -17.66 Mn |
| Sep 30, 2025 | -20.05 Mn |
| Jun 30, 2025 | -14.74 Mn |
| Mar 31, 2025 | -15.36 Mn |
| Dec 31, 2024 | -13.83 Mn |
| Sep 30, 2024 | -12.97 Mn |
| Jun 30, 2024 | -15.28 Mn |
| Mar 31, 2024 | -11.92 Mn |
| Dec 31, 2023 | -11.00 Mn |
| Sep 30, 2023 | -11.72 Mn |
| Jun 30, 2023 | -23.07 Mn |
| Mar 31, 2023 | -17.33 Mn |
| Dec 31, 2022 | -22.40 Mn |
| Sep 30, 2022 | -23.91 Mn |
| Jun 30, 2022 | -21.48 Mn |
| Mar 31, 2022 | -19.02 Mn |
| Dec 31, 2021 | -14.58 Mn |
| Sep 30, 2021 | -10.76 Mn |
| Jun 30, 2021 | -25.95 Mn |